Cintia PharmD - Allovir Chief Officer
| ALVRDelisted Stock | USD 9.81 0.15 1.55% |
Executive
Cintia PharmD is Chief Officer of Allovir
| Age | 52 |
| Phone | 617 433 2605 |
| Web | https://www.allovir.com |
Allovir Management Efficiency
The company has return on total asset (ROA) of (0.3653) % which means that it has lost $0.3653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8033) %, meaning that it created substantial loss on money invested by shareholders. Allovir's management efficiency ratios could be used to measure how well Allovir manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Marc CPA | Crinetics Pharmaceuticals | 45 | |
| Monique Silva | AnaptysBio | N/A | |
| Yan MBA | Adagene | 50 | |
| MSc MD | AnaptysBio | N/A | |
| Bonne MBA | Inhibrx | 48 | |
| Alan MD | Crinetics Pharmaceuticals | 62 | |
| An Song | 4D Molecular Therapeutics | N/A | |
| Daniel George | Anebulo Pharmaceuticals | 55 | |
| Eric Olson | Stoke Therapeutics | N/A | |
| Matthew JD | Lyell Immunopharma | 49 | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Christopher Taylor | Agios Pharm | N/A | |
| Gayathri Diwakar | Crinetics Pharmaceuticals | N/A | |
| Karen Carothers | 4D Molecular Therapeutics | 74 | |
| Joshua JD | AN2 Therapeutics | 47 | |
| Dr MBA | Acrivon Therapeutics, Common | N/A | |
| Gregory Perry | Merus BV | 65 | |
| Jennifer Huber | AN2 Therapeutics | N/A | |
| Marc Wilson | Crinetics Pharmaceuticals | 45 | |
| Barbara JD | Kronos Bio | 65 | |
| Sanjeev Khindri | Aerovate Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.37 |
Allovir Leadership Team
Elected by the shareholders, the Allovir's board of directors comprises two types of representatives: Allovir inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Allovir. The board's role is to monitor Allovir's management team and ensure that shareholders' interests are well served. Allovir's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Allovir's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sonia Choi, Senior Relations | ||
| Agustin MD, Advisor | ||
| Dana MBA, VP Operations | ||
| Ann Leen, Chief Officer | ||
| Cintia PharmD, Chief Officer | ||
| David Hallal, Executive Board | ||
| Jeroen Beek, Consultant | ||
| Diana MD, CEO Director | ||
| Ugo Perlingieri, Head Operations | ||
| Brett Hagen, Chief Officer | ||
| Edward JD, General Secretary | ||
| Dana Alexander, Senior Operations |
Allovir Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Allovir a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (69.57 M) | ||||
| Shares Outstanding | 115.36 M | ||||
| Shares Owned By Insiders | 49.11 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 64.61 K | ||||
| Price To Book | 0.43 X | ||||
| Gross Profit | 165 K | ||||
| EBITDA | (65.44 M) |
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving together with Allovir Stock
Moving against Allovir Stock
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allovir. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Allovir Stock
If you are still planning to invest in Allovir check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allovir's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |